Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg).
Samuel Jesús Martínez DomínguezOlga P NyssenÁngel LanasEnrique AlfaroLaimas JonaitisUmud MahmudovIrina VoynovanBabayeva GülüstanLuis RodrigoGiulia FioriniÁngeles Perez-AisaJavier Tejedor-TejadaBojan TepesLudmila VologzaninaEmin MammadovFrode LerangQuliyev Fərid Vidadi OğluNatalia V BakulinaRustam AbdulkhakovIlchishina TatianaThomas J ButlerAiman Silkanovna SarsenbaevaRenate BumaneAlfredo J LucendoMarco RomanoLuis BujandaSayar R AbdulkhakovOleg ZaytsevManuel Pabón-CarrascoAlma Keco-HuergaMaja DenkovskiJose M HuguetMonica PeronaÓscar NúñezMatteo PavoniGalyna FadieienkoSergey AlekseenkoSinead M SmithLuis HernándezJuozas KupcinskasDmitry S BordinMārcis LejaAntonio GasbarriniOleksiy GridnyevAnna Cano-CatalàPablo ParraLeticia MoreiraFrancis MégraudColm O'MorainJavier P Gisbertnull nullPublished in: Helicobacter (2024)
ClinicalTrials.gov identifier: NCT02328131.